Investigational Site Number 8400079

Albany, New York 12206

0 studies enrolling now · 1 studies all time

What they study most

Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period — Completed